Harvest Health reports its Results For Q4 2019.
Harvest Health & Recreation Inc. (CSE: HARV), a vertically integrated cannabis company and multi-state operator (MSO) in the U.S., today reported its financial and operating results for the fourth quarter and year ended 2019. All financial information is provided in U.S. dollars unless otherwise indicated.
Fourth Quarter and Full Year 2019 Financial Highlights
- Total revenue in the fourth quarter was $37.8 million, an increase of 123% from $16.9 million in the fourth quarter of 2018 and up 14%, compared to $33.2 million in the third quarter of 2019. Full year revenue increased 149% to $116.8 million in 2019 compared to $47.0 million in 2018.
- Gross profit excluding biological adjustments in the fourth quarter was $16.0 million, compared to $11.6 million in the third quarter of 2019. Gross profit excluding biological adjustments for the full year was $42.2 million compared to $24.6 million in 2018.
- Gross profit margin excluding biological adjustments in the fourth quarter was 42.3%, compared to 35.0% for the third quarter of 2019. Gross profit margin excluding biological adjustments for the full year was 36.1% compared to 52.3% in 2018.
- Adjusted EBITDA excluding biological adjustments in the fourth quarter was ($6.8) million, compared to ($10.9) million in the third quarter of 2019. Adjusted EBITDA excluding biological adjustments for the full year was ($34.8) million, compared to $7.9 million in 2018.
- Net loss was $88.9 million for the fourth quarter compared to net loss of $71.1 million during the fourth quarter 2018. Net loss for the full year was $173.5 million compared to net loss of $67.5 million in 2018.
Fourth Quarter Highlights
- New capital raised by Harvest included $6.5 million of real estate backed debt, approximately $47.3 million of short-term debt, $10 million in convertible debt and $30 million in senior secured debt. During the quarter approximately $84 million of debt was exchanged into our new senior secured debt, including the short-term debt totaling approximately $47.3 million raised during the fourth quarter.
- Harvest opened four new retail locations in California and Pennsylvania and added one operational retail location in Maryland through a managed services agreement.
- Harvest was awarded one of two retail permits in Hanford, California by achieving the top score amongst all applicants.
- Founding shareholders agreed to a voluntary six-month lockup extension in November covering approximately 19.5 million shares.
- Ana Dutra and Eula Adams were appointed to the Board of Directors, adding valuable experience in financial and corporate management disciplines.
- Harvest announced the addition of Daniel Reiner as a special advisor to the board and Scott Atkison as a future board member.
- CannApprove testing and safety protocols were implemented covering THC vape products manufactured by Harvest.
Full Year Highlights
- New capital raised during 2019 included short-term debt, unsecured convertible debt, real estate backed debt, and senior secured debt totaling approximately $295 million.
- Harvest added 21 retail locations through a combination of organic store openings, acquisitions of operational retail locations, and addition of stores through managed service agreements. At year end, Harvest owned, operated, or managed 31 retail locations in six states, including 11 in Arizona.
- Harvest was awarded licenses allowing for up to 10 additional revenue generating facilities including cultivation and manufacturing facilities and retail dispensaries.
- New capital raised subsequent to 2019 included $20 million of real estate backed debt, $21.3 million in senior secured debt, and $59 million in equity.
- Harvest added five retail locations through a combination of organic store openings and acquisitions of operational retail locations in Arizona, Arkansas, and Michigan. As of April 3, 2020, Harvest owned, operated, or managed 35 retail locations in seven states, including 14 open dispensaries in Arizona. Harvest owned and operated dispensaries exclude retail locations serviced through Interurban Capital Group.
- Harvest completed the acquisition of Franklin Labs on March 26, 2020, adding cultivation and manufacturing capabilities to its operations in Pennsylvania. The cultivation facility is operational and manufacturing activities are expected to commence during the second quarter of 2020.
- The acquisition of Interurban Capital Group was completed on March 13, 2020, adding strategic investors to the shareholder base and direct and indirect licenses in California and Iowa and rights to acquire assets and provide cannabis retail support services for dispensaries in California, Iowa and Washington.
- The acquisition of Arizona Natural Selections was completed on February 18, 2020, adding three open retail locations, an indoor cultivation facility, greenhouse cultivation facility and potential outdoor cultivation to Harvest's existing operational footprint in Arizona. The acquisition included a fourth vertical license in Arizona and the Darwin product line.
- Harvest announced an agreement to acquire the operations of a cultivation and manufacturing facility in Nevada from MJardin Group in January 2020.
- Harvest announced legal action seeking the termination of the merger agreement with Falcon International in January 2020.
- The company announced a mutual agreement with Verano Holdings to terminate the pending business combination agreement on March 25, 2020. No breakup fees are required by either party as part of the termination agreement.
- Three members of senior leadership surrendered 2.4 million option awards to contribute to a new equity option award totaling 3.0 million options in February 2020.
- Mark Barnard assumed the role of Chairman of the Board in March 2020.
- Ron Goodson joined Harvest as Chief Operating Officer in January 2020.
Harvest is committed to the health and well-being of patients, customers, and the communities in which we operate. As operators of primarily medical retail dispensaries, the company is working to ensure continued service for patients in need during this challenging time. Stakeholders are encouraged to visit our microsite https://covid19.harvesthoc.com regularly for updates.
We expect to report first quarter 2020 sequential revenue growth in line with the sequential revenue growth reported for the fourth quarter 2019.
"2019 was an important investment year for our company. Harvest exited the year with a broader retail presence, expanded cultivation and manufacturing operations, and greater support infrastructure needed to achieve operational efficiencies and return to profitability," said Chief Executive Officer Steve White.
Moving forward we believe Harvest has the assets and capital required to succeed long-term in the cannabis industry.Harvest Health's CEO, Steve White.
Non-IFRS Financial and Performance Measures
The Company provides additional financial metrics that are not prepared in accordance with IFRS. Management uses non-IFRS financial measures, in addition to IFRS financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate the Company's financial performance. This non-IFRS financial measure is Adjusted EBITDA.
Management believes that these non-IFRS financial measures reflect the Company's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as they facilitate comparing financial results across accounting periods and to those of peer companies. Management also believes that these non-IFRS financial measures enable investors to evaluate the Company's operating results and future prospects in the same manner as management. These non-IFRS financial measures may also exclude expenses and gains that may be unusual in nature, infrequent or not reflective of the Company's ongoing operating results.
As there are no standardized methods of calculating these non-IFRS measures, the Company's methods may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similarly titled measures used by others. Accordingly, these non-IFRS measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.
Reconciliations of Non-IFRS Financial and Performance Measures
The table below reconciles Net Loss to Adjusted EBITDA for the periods indicated.
To learn more about Harvest Health, visit the company HQ here.
Disclaimer: Past performance is not an indicator of future performance.
& Keep Up to Date
Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!